MedPath

Evaluation of the Postoperative Agitation Prevention and Analgesic Efficacy of Perioperative Dexmedetomidine Infusion in a Pediatric Patient Group to Undergo Tonsillectomy and Adenoidectomy

Completed
Conditions
Anxiety
Postoperative Pain
Bleeding
Interventions
Registration Number
NCT05986942
Lead Sponsor
Burak Omur
Brief Summary

Dexmedetomidine is a drug known for its pain-relieving and restlessness-reducing effects. The purpose of this run is to use the association between this use during surgery and the attrition of post-operative pain and discomfort. In the research, laboratory and monitoring results will be obtained before, during and after the operation. Postoperative patient complaints will be evaluated at the postoperative service visit. This study is decided on a completely voluntary basis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients with ASA 1-2, aged 2-10 years, scheduled for elective tonsillectomy and/or adenoidectomy operation will be included.

Exclusion Criteria

developmental delay anxiety disorder Known history of allergy to alpha-2 agonistic agents use of antipsychotic medication beta blocker use of anticonvulsant drugs chronic pain syndrome with cardiac and craniofacial anomalies

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
DexDexmedetomidinepatients using dexmedetomidine infusion
FenFentanylpatients using fentanyl for induction
Primary Outcome Measures
NameTimeMethod
postoperative painPain was evaluated at 0, 2, 4, 6 and 8 hours postoperatively.

Postoperative pain level will be measured using the FLACC pain scale (face, legs, activity, cry, consolability). 4 and above will be considered as high pain level, below 4 as low pain level.

postoperative anxietyanxiety was evaluated at 0, 2, 4, 6 and 8 hours postoperatively.

Postoperative anxiety level will be measured using the Pediatric Anesthesia Emergence Delirium Scale (PAED). A value of 12 and above will be considered high anxiety, and values below 12 will be considered low anxiety.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Istanbul Medipol University

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath